• No results found

University of Groningen Paving the way for pulmonary influenza vaccines Tomar, Jasmine

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Paving the way for pulmonary influenza vaccines Tomar, Jasmine"

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Paving the way for pulmonary influenza vaccines

Tomar, Jasmine

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2018

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Tomar, J. (2018). Paving the way for pulmonary influenza vaccines: Exploring formulations, models and site of deposition. University of Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

Paving the Way for Pulmonary

Influenza Vaccines

Exploring formulations, models and site of deposition

(3)

Cover design

Tushar Tomar and Pharma Pulse

Printing

PrintSupport4U

Layout

Pharma Pulse (www.pharmapulse.net)

Thesis printing was financially supported by

The research presented in this thesis was financially supported by

European Union Seventh Framework Program 19 (FP7/2007-2013) and Universal Influenza Vaccines Secured (UNISEC) consortium under grant agreement no. 602012. It was also supported by the Dutch Ministry of Economic Affairs (WOT-01-003-067; KB-21-006-012).

Dissertation of University of Groningen, Groningen, The Netherlands

ISBN : 978-94-034-1168-2 (printed) ISBN: 978-94-034-1167-5 (digital) © Jasmine Tomar, Groningen, 2018 email ID: tomarjasmine@gmail.com

All rights reserved. No parts of this thesis may be reproduced or transmitted in any form or by any means, without written permission from the author.

Graduate School of Science and Engineering (GSSE)

Innovative Research of America

PerkinElmer Southern Biotech

ChipSoft Abcam Greiner bio-one

(4)

Paving the Way for

Pulmonary Influenza Vaccines

Exploring formulations, models and site of deposition

PhD thesis

to obtain the degree of PhD at the University of Groningen

on the authority of the Rector Magnificus Prof. E. Sterken

and in accordance with the decision by the College of Deans. This thesis will be defended in public on

Friday 7 December 2018 at 14.30 hours

by

born on 17 August 1989 in Kaithal, India

(5)

Supervisors

Prof. dr. H.W. Frijlink Prof. dr. A.L.W. Huckriede

Co-supervisor

Dr. W.L.J. Hinrichs

Assessment Committee

Prof. dr. G.F. Kersten Prof. dr. C.A.H.H. Daemen Prof. dr. D. Christensen

(6)
(7)

Paranymphs

Gerian Prins Atul Vatts

(8)

Chapter 1 Introduction and outline of this thesis

Chapter 2 Dry influenza vaccines: towards a stable, effective and convenient

alternative to conventional parenteral influenza vaccination

Chapter 3 Pulmonary delivery of influenza vaccine formulations in cotton rats:

site of deposition plays a minor role in the protective efficacy against clinical isolate of H1N1pdm virus

Chapter 4 Pulmonary immunization: deposition site is of minor relevance for

influenza vaccination but deep lung deposition is crucial for hepatitis B vaccination

Chapter 5 Advax augments B and T cell responses upon influenza vaccination

via the respiratory tract and completely protects mice against lethal influenza virus challenge

Chapter 6 Passive inhalation of dry powder influenza vaccine formulations

completely protects chickens against H5N1 lethal viral challenge

Chapter 7 Summary, concluding remarks, and perspectives Appendices

III Nederlandse Samenvatting

III Curriculum vitae with list of publications

III Acknowledgements

Contents

9 15 53 83 105 137 161 173 175 181 187

(9)

Referenties

GERELATEERDE DOCUMENTEN

In order to determine the relative efficacy of WIV vaccines combined with different adjuvants, mice were vaccinated three times via the most suitable route of administration with

To explore the immune mechanisms involved in protection from weight loss and lung virus growth upon challenge, antibody responses induced by sequential infection with PR8 and X-31

Mice were vaccinated twice as described above with modified NC99 (H1N1)-derived virosomes with admixed or attached HK68 NP, with HK68 NP + MPLA or with plain virosomes and

Despite the overt effects of vaccination on lung virus titers several observations indicate that vaccination did not result in sterilizing immunity: (i) the breathing frequency

In Chapter 3, pulmonary administration of a whole inactivated influenza virus powder vaccine formulation was compared to a liquid formulation in a cotton rat model with respect to

Sproei-vriesdrogen werd gebruikt om een droogpoeder te produceren met een deeltjesgrootte die geschikt is voor inhalatie (1-5 mm). Ondanks het feit dat de poederdeeltjes de

In Chapter 3, pulmonary administration of a whole inactivated influenza virus powder vaccine formulation was compared to a liquid formulation in a cotton rat model with respect to

2) Site of deposition within the respiratory tract holds minor relevance for inhaled vaccines against air-borne infectious diseases such as influenza but deep lung deposition is